id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2021-0030-0005,DEA,DEA-2021-0030,Schedules of Controlled Substances: Placement of Methoxetamine (MXE) in Schedule I,Rule,,2022-06-06T04:00:00Z,2022,6,2022-06-06T04:00:00Z,,2022-06-06T13:54:29Z,2022-11933,0,0,0900006485141202
DEA-2021-0030-0003,DEA,DEA-2021-0030,DEA568 8 Factor Methoxetamine 092021,Supporting & Related Material,,2021-12-08T05:00:00Z,2021,12,,,2021-12-08T20:11:47Z,,0,0,0900006484eac53f
DEA-2021-0030-0002,DEA,DEA-2021-0030,HHS Scheduling recommendation Methoxetamine,Supporting & Related Material,,2021-12-08T05:00:00Z,2021,12,,,2021-12-08T20:11:38Z,,0,0,0900006484eac53d
DEA-2021-0030-0001,DEA,DEA-2021-0030,Schedules of Controlled Substances: Placement of Methoxetamine in Schedule I,Proposed Rule,,2021-12-07T05:00:00Z,2021,12,2021-12-07T05:00:00Z,2022-02-08T04:59:59Z,2021-12-11T02:00:42Z,2021-26293,0,0,0900006484ea7915